Analysis ID: SDA-2026-04-14-gap-pubmed-20260410-185318-186b0446 | Domain: neurodegeneration | Status: failed | Created: 2026-04-14T12:12:29.481144
#1 APOE4 Isoform Correction via Lipidation Enhancement as CTE Risk Mitigation
0.552
APOE
APOE ε4 carriers demonstrate ~3x increased AD risk and show accelerated tau PET uptake in former contact sport athletes. The ε4 isoform exhibits impaired lipid transport function, reduced synaptic pro